Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study. [PDF]
Int J Womens HealthDeng J +6 more
europepmc +1 more source
Cytoreductive nephrectomy: a treatment of the past
Canadian Urological Association Journal, 2013 openaire +3 more sources
Case Report: Genotype-informed management after clinically necessary cytoreduction for giant recurrent gastric gastrointestinal stromal tumor with prior rupture and KIT exon 17 N822Y mutation. [PDF]
Front OncolRui J +10 more
europepmc +1 more source
Feasibility and Prognostic Value of an Ovarian NAR-like Score in Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery. [PDF]
J Clin MedÖzkaya Uçar Y +7 more
europepmc +1 more source
Prognostic value of CA125, HE4, ROMA, and CPH-I in advanced epithelial ovarian cancer. [PDF]
BMC CancerZhao M +6 more
europepmc +1 more source
Exploratory analysis of serial pan-immune-inflammation value and its early dynamics during neoadjuvant chemotherapy as a predictor of complete cytoreduction at interval debulking surgery in advanced ovarian cancer: a retrospective cohort study. [PDF]
World J Surg OncolSu H +7 more
europepmc +1 more source
Predictive factors for long-term survivors in advanced-stage epithelial ovarian cancer. [PDF]
AJOG Glob RepManchana T, Assavapokee N.
europepmc +1 more source
Low-grade serous ovarian cancer in Indonesia: Insights from the largest multicenter cohort in a middle-income country. [PDF]
Mol Clin OncolTjokroprawiro BA +14 more
europepmc +1 more source